3839 — CPBIO Holding Share Price
Last trade - 00:00- HK$1.90bn
- HK$2.46bn
- $535.91m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.82 | ||
| Price to Tang. Book | 0.83 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.57 | ||
| EV to EBITDA | 9.8 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.28% | ||
| Return on Equity | 8.89% | ||
| Operating Margin | 7.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 142.41 | 159.24 | 173.98 | 307.75 | 535.91 | n/a | n/a | 41.77% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +20.83 | n/a | n/a | +309.1 | +217.11 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CPBIO Holding Company Ltd, formerly Chia Tai Enterprises International Ltd, is a company principally engaged in the biotech business. The Company operates business through two segments. The Biotech Business segment mainly engaged in the manufacture and sale of animal health products and chlortetracycline(CTC). The Investment Business segment is mainly involved in the trading of machinery as well as the manufacture and sale of automotive parts through the Group’s joint venture and associate.
Directors
- Soopakij Chearavanont NEC (57)
- Thirayut Phityaisarakul CEX (73)
- Thanakorn Seriburi CEX (69)
- Nopadol Chiaravanont EDR (54)
- Chawalit Na Muangtoun EDR (52)
- Mei Wah Ng SEC (42)
- Yoichi Ikezoe NED (62)
- Yuk Wo Cheng NID (60)
- Ming Tung Ko NID (60)
- Surasak Rounroengrom NID (61)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- October 16th, 1987
- Public Since
- July 3rd, 2015
- No. of Employees
- 1,000
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 240,718,310
- Address
- 21/F,
- Web
- https://www.cp-bio.com
- Phone
- +852 null25201601
- Auditors
- KPMG
Latest News for 3839
Upcoming Events for 3839
Q3 2026 CPBIO Holding Company Ltd Earnings Release
Q4 2026 CPBIO Holding Company Ltd Earnings Release
Similar to 3839
Befar
Stock Exchange of Hong Kong Limited
China Gas Industry Investment Holdings
Stock Exchange of Hong Kong Limited
Zhejiang ChangAn Renheng Technology
Stock Exchange of Hong Kong Limited
Changmao Biochemical Engineering
Stock Exchange of Hong Kong Limited
China Longevity
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 02:07 UTC, shares in CPBIO Holding are trading at HK$7.90. This share price information is delayed by 15 minutes.
Shares in CPBIO Holding last closed at HK$7.90 and the price had moved by -5.95% over the past 365 days. In terms of relative price strength the CPBIO Holding share price has underperformed the FTSE Developed Asia Pacific Index by -31.31% over the past year.
There is no consensus recommendation for this security.
Find out moreCPBIO Holding does not currently pay a dividend.
CPBIO Holding does not currently pay a dividend.
CPBIO Holding does not currently pay a dividend.
To buy shares in CPBIO Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$7.90, shares in CPBIO Holding had a market capitalisation of HK$1.90bn.
Here are the trading details for CPBIO Holding:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 3839
Based on an overall assessment of its quality, value and momentum CPBIO Holding is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CPBIO Holding. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +12.49%.
As of the last closing price of HK$7.90, shares in CPBIO Holding were trading +0.66% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CPBIO Holding PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$7.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CPBIO Holding's management team is headed by:
- Soopakij Chearavanont - NEC
- Thirayut Phityaisarakul - CEX
- Thanakorn Seriburi - CEX
- Nopadol Chiaravanont - EDR
- Chawalit Na Muangtoun - EDR
- Mei Wah Ng - SEC
- Yoichi Ikezoe - NED
- Yuk Wo Cheng - NID
- Ming Tung Ko - NID
- Surasak Rounroengrom - NID